Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Market Cap	671.47M
Revenue (ttm)	628.03M
Net Income (ttm)	38.68M
Shares Out	n/a
EPS (ttm)	1.09
PE Ratio	17.36
Forward PE	n/a
Dividend	0.47 (2.55%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	n/a
Open	18.60
Previous Close	18.20
Day's Range	18.60 - 18.60
52-Week Range	16.20 - 22.40
Beta	n/a
RSI	68.63
Earnings Date	Feb 6, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p...

• Industry: Pharmaceutical Preparations
• Founded: 1913
• Employees: 1,508
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MFY

Financial Performance

In 2024, Mochida Pharmaceutical's revenue was 105.16 billion, an increase of 2.21% compared to the previous year's 102.89 billion. Earnings were 5.69 billion, an increase of 25.03%.

Financial numbers in JPY